Micromolds supported the industrialization and optimization of a microfluidic chip manufacturing process for a next-generation point-of-care diagnostic system. The device is designed to deliver rapid, lab-quality results from small-volume samples in decentralized environments. This project demonstrates Micromolds' capability to translate microfluidic designs into stable, manufacturable components while maintaining micron-level precision, repeatability, and process control. PM

Microfluidic product development plays a critical role in modern diagnostics, life sciences, and analytical systems, enabling the creation of compact devices that precisely control small volumes of fluids for testing, detection, and processing. Manufacturability in microfluidic product development is determined by how well channel geometry, material behavior, bonding strategy, and process constraints are aligned with real manufacturing conditions. These include factors such a

Certification underscores company’s commitment to quality management and reliable manufacturing for medical and microfluidic applications Precision micro injection molding company Micromolds has achieved ISO 13485 certification, confirming that its quality management system meets internationally recognized standards for medical device manufacturing. The certification further strengthens Micromolds’ position as a trusted partner for engineering teams developing high-precision

Microfluidic technologies are transforming modern diagnostics, biotechnology, and analytical chemistry. Many of these systems rely on microfluidic chips containing microscopic channels that guide small volumes of liquids for chemical reactions, biological assays, or sample analysis. As microfluidic products move from laboratory prototypes to commercial applications, manufacturers face a key challenge: how to produce microfluidic devices at industrial scale while maintaining

Metyos , a Paris-based deeptech medical company, is developing a smart biowearable designed to transform how potassium levels are monitored in patients at risk of dyskalemia — a clinical term describing abnormal potassium levels in the blood. Dyskalemia encompasses both hyperkalemia (elevated serum potassium) and hypokalemia (reduced serum potassium), two clinically significant electrolyte disturbances frequently observed in patients with renal and cardiovascular conditions.

Creating microfluidic devices is a precise and demanding engineering process. Many teams begin with microfluidics fabrication methods such as PDMS casting, micro milling, laser machining, or 3D printing. These techniques are ideal for validating flow behavior and testing early designs. However, when the device moves beyond prototyping and toward commercial production, fabrication alone is no longer enough. At that stage, micro injection molding becomes critical. This article